DiaMedica Therapeutics In...

NASDAQ: DMAC · Real-Time Price · USD
4.17
0.08 (1.96%)
At close: Jun 06, 2025, 9:30 AM

DiaMedica Therapeutics Statistics

Share Statistics

DiaMedica Therapeutics has 42.88M shares outstanding. The number of shares has increased by 12.89% in one year.

42.88M
12.89%
0.22%
15.74%
n/a
7,664
7.88%

Short Selling Information

The latest short interest is 856.93K, so 2% of the outstanding shares have been sold short.

856.93K
2%
3.17%
8.9

Valuation Ratios

The PE ratio is -8.98 and the forward PE ratio is -5.25. DiaMedica Therapeutics's PEG ratio is 0.

-8.98
-5.25
0
2.2
5.39
-9.93
0
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for DiaMedica Therapeutics.

n/a
n/a
n/a
n/a

Financial Position

The company has a current ratio of 8.28, with a Debt / Equity ratio of 0.01.

8.28
8.28
0.01
-0.01
-0.02
0

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

n/a
n/a
n/a
n/a
$-905,333.33
27
0
n/a

Taxes

30K
-0.12%

Stock Price Statistics

The stock price has increased by 49.82% in the last 52 weeks. The beta is 1.2, so DiaMedica Therapeutics's price volatility has been higher than the market average.

1.2
49.82%
3.93
4.74
49.51
97,222

Income Statement

n/a
n/a
-26.68M
-24.44M
-24.38M
-24.41M
-0.6
Full Income Statement

Balance Sheet

The company has 3.02M in cash and 340K in debt, giving a net cash position of 2.69M.

3.02M
340K
2.69M
-140M
38.83M
32.76M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -22.08M and capital expenditures -25K, giving a free cash flow of -22.1M.

-22.08M
-25K
-22.1M
-0.55
Full Cash Flow Statement

Margins

n/a
n/a
n/a
n/a
n/a
n/a
n/a

Dividends & Yields

DMAC does not appear to pay any dividends at this time.

n/a
n/a
n/a
n/a
n/a
n/a
Dividend Details

Analyst Forecast

The average price target for DMAC is $8, which is 95.6% higher than the current price. The consensus rating is "Buy".

$8
95.6%
Buy
2
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

n/a
n/a
n/a
n/a

Stock Splits

The last stock split was on Nov 15, 2018. It was a backward split with a ratio of 1:20.

Nov 15, 2018
backward
1:20

Scores

15.17
2